Pharma news
Americas
Raj Panjabi was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 9 November 2017
Americas
Sovereign immunity has been used to harm the IP system in recent years, according to Bob Goodlatte, chairman of the House Judiciary Committee. 9 November 2017
Pharma
The Danish Maritime and Commercial High Court has invalidated a supplementary protection certificate (SPC) owned by Gilead. 9 November 2017
Pharma
Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High Court. 8 November 2017
Pharma
Switzerland-based Roche has confirmed it will provide a cancer drug free of charge after an altercation with the Greek government. 7 November 2017
Americas
Cindy Ahn, a former counsel at Schiff Hardin, has joined private equity firm Longford Capital to help handle demand for litigation finance among life sciences and biotech firms. 6 November 2017
Americas
Pharmaceutical companies have entered into fewer potential ‘pay-for-delay’ patent settlements for the second year in a row, following the US Supreme Court’s decision in FTC v Actavis. 6 November 2017
Americas
A US House of Representatives committee has called a hearing on the issue of IP rights being owned by entities that claim sovereign immunity. 6 November 2017
Americas
Watson Laboratories has secured a win at the US Court of Appeals for the Federal Circuit, after the court said Watson did prove that Bayer’s patent claims were obvious. 2 November 2017
Pharma
The English Court of Appeal has ruled that patent claims protecting blockbuster drug Cialis (tadalafil) are invalid as obvious, handing victory to Actavis, Teva and Mylan. 1 November 2017